Cheryl Waters is a Neurology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 207 publications with 10,335 citations (h-index 55).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
710 W 168th St
New York, NY 100323726
Telephone
212-305-3665Registry record last updated 18 Mar 2013.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- MDD US Operations, LLCProgram year20258 payments
- ABBVIE INC.Program year20251 payment
- MDD US Operations, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
95.2%Aromatic Amino Acid Decarboxylation Inhibitor56.1%Carbidopa-Levodopa71%Carbidopa-Levodopa Er25%Rytary4%Part D≥272 patientsInfluenza A M2 Protein Inhibitor7.2%Amantadine55%Gocovri45%Part D≥32 patients+ 16 more classes in this area
Cardiovascular
1.9%Adrenergic and dopaminergic agents1.1%Droxidopa100%Part D<11 patientsBeta blocker0.8%Propranolol Hcl100%Part D<11 patientsHormonal (systemic)
1.6%Mineralocorticoids1.6%Fludrocortisone Acetate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
Science Translational Medicine
2023 - <i>SMPD1</i> mutations, activity, and α‐synuclein accumulation in Parkinson's disease
Movement Disorders
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Fahn, MD
Columbia University Irving Medical Center
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”